> top > projects > sentences > docs > PubMed:10052590 > annotations
sentences Home  

PubMed:10052590 JSONTXT 26 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-142 Sentence denotes A novel method for determination of alpha1,6fucosyltransferase activity using a reducing oligosaccharide from egg yolk as a specific acceptor.
T1 0-142 Sentence denotes A novel method for determination of alpha1,6fucosyltransferase activity using a reducing oligosaccharide from egg yolk as a specific acceptor.
TextSentencer_T2 143-232 Sentence denotes A new method for determination of alpha1,6fucosyltransferase activity has been described.
T2 143-232 Sentence denotes A new method for determination of alpha1,6fucosyltransferase activity has been described.
TextSentencer_T3 233-352 Sentence denotes Recently, the disialyl-biantennary undecasaccharide was prepared in high yield from egg yolk [(1996), Carbohydr Lett 2:
T3 233-352 Sentence denotes Recently, the disialyl-biantennary undecasaccharide was prepared in high yield from egg yolk [(1996), Carbohydr Lett 2:
TextSentencer_T4 353-361 Sentence denotes 137-42].
T4 353-361 Sentence denotes 137-42].
TextSentencer_T5 362-593 Sentence denotes By treatment of this oligosaccharide with neuraminidase and beta-galactosidase, we readily obtained an asialo-agalacto-biantennary heptasaccharide (GlcNAcbeta 1,2Manalpha1,6[GlcNAcbeta1,2Manalpha1,3]Manbeta1 ,4GlcNAcbeta1,4GlcNAc).
T5 362-593 Sentence denotes By treatment of this oligosaccharide with neuraminidase and beta-galactosidase, we readily obtained an asialo-agalacto-biantennary heptasaccharide (GlcNAcbeta 1,2Manalpha1,6[GlcNAcbeta1,2Manalpha1,3]Manbeta1 ,4GlcNAcbeta1,4GlcNAc).
TextSentencer_T6 594-788 Sentence denotes Using this asialo-agalacto-oligosaccharide as an acceptor, fucosyltransferases from human plasma and extracts of various human hepatoma cell lines were assayed in the presence of GDP-[3H]fucose.
T6 594-788 Sentence denotes Using this asialo-agalacto-oligosaccharide as an acceptor, fucosyltransferases from human plasma and extracts of various human hepatoma cell lines were assayed in the presence of GDP-[3H]fucose.
TextSentencer_T7 789-893 Sentence denotes The reaction mixture was applied to a column of GlcNAc-binding, Psathyrella velutina lectin coupled gel.
T7 789-893 Sentence denotes The reaction mixture was applied to a column of GlcNAc-binding, Psathyrella velutina lectin coupled gel.
TextSentencer_T8 894-983 Sentence denotes All the fucosylated acceptor were bound to the column which was eluted with 50 mM GlcNAc.
T8 894-983 Sentence denotes All the fucosylated acceptor were bound to the column which was eluted with 50 mM GlcNAc.
TextSentencer_T9 984-1214 Sentence denotes Structural analyses revealed that only the innermost GlcNAc residue of the acceptor was fucosylated through an alpha1,6-linkage, and the oligosaccharide prepared could be used as a specific acceptor for alpha1,6fucosyltransferase.
T9 984-1214 Sentence denotes Structural analyses revealed that only the innermost GlcNAc residue of the acceptor was fucosylated through an alpha1,6-linkage, and the oligosaccharide prepared could be used as a specific acceptor for alpha1,6fucosyltransferase.
TextSentencer_T10 1215-1484 Sentence denotes The present method was used to screen plasma alpha1,6fucosyltransferase in several patient groups, and significantly elevated activities were found in samples from patients with liver diseases, including chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
T10 1215-1484 Sentence denotes The present method was used to screen plasma alpha1,6fucosyltransferase in several patient groups, and significantly elevated activities were found in samples from patients with liver diseases, including chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.